In a recent video interview, Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, introduces OSD Predict, a cutting-edge predictive modeling platform that aims to enhance the efficiency and speed of oral solid dose delivery. This innovative toolbox features multiple tools designed to revolutionize drug formulation and development, including advanced modeling for solubility, compaction simulations, and stability predictions.
OSD Predict streamlines the candidate selection process while minimizing trial and error, significantly shortening the timeline from Phase 1 to Phase 2 and beyond. By integrating AI and machine learning, this platform leverages extensive data for robust predictions, ultimately ensuring that effective medicines reach patients faster.
Don’t miss this great interview to learn more about how OSD Predict can transform drug development and create impactful benefits for the pharmaceutical industry.